Reduced pulmonary clearance of endothelin in congestive heart failure: A marker of secondary pulmonary hypertension

Journal of Cardiac Failure

Volumn 10, Issue 5, 2004, Pages 427-432

  Staniloae, Cezar ^a,b   Dupuis, Jocelyn ^a,b   White, Michel ^a,b   Gosselin, Gilbert ^a,b   Dyrda, Ihor ^a,b   Bois, Marc ^a,b   Crépeau, Jacques ^a,b   Bonan, Raoul ^a,b   Caron, Alexandre ^a,b   Lavoie, Joël ^a,b  

^a Montreal Heart Institute ^*

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Endothelial function; Endothelins; Heart failure; Pulmonary circulation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; MARKER; BIOLOGICAL MARKER; NERVE PROTEIN; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DILUTION; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG CLEARANCE; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICAL ANALYSIS; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; HEART VENTRICLE; INDICATOR DILUTION CURVE; LUNG; LUNG WEDGE PRESSURE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; ENDOTHELIN-1; FEMALE; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; INDICATOR DILUTION TECHNIQUES; LUNG; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PULMONARY CIRCULATION; PULMONARY WEDGE PRESSURE; REGRESSION ANALYSIS;

EID: 2942529134     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.01.008     Document Type: Article

References (28)

1. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9.
2. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-9.
3. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580-6.
4. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994;89:1573-9.
5. Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, et al. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Failure 2000;6:201-7.
6. Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996;94:1578-84.
7. Dupuis J, Goresky CA, Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol 1996;81:1510-5.
8. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994;199:1461-5.
9. de Nucci G, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 1988;85:9797-800.
10. McCulloch KM, MacLean MR. EndothelinB receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J Cardiovasc Pharmacol 1995;26(Suppl 3):S169-76.
11. D'Orleans-Juste P, Claing A, Telemaque S, Maurice MC, Yano M, Gratton JP. Block of endothelin-1-induced release of thromboxane A2 from the guinea pig lung and nitric oxide from the rabbit kidney by a selective ETB receptor antagonist, BQ-788. Br J Pharmacol 1994;113:1257-62.
12. Sutsch G, Kiowski W, Yan XW, Hunziker P, Christen S, Strobel W, et al. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 1998;98:2262-8.
13. Dupuis J, Moe GW, Cernacek P. Reduced pulmonary metabolism of endothelin-1 in canine tachycardia-induced heart failure. Cardiovasc Res 1998;39:609-16.
14. Dupuis J, Rouleau JL, Cernacek P. Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. Circulation 1998;98:1684-7.
15. B receptor-mediated clearance of endothelin-1? Life Sci 1998;62:185-93.
16. Dupuis J, Goresky CA, Stewart DJ. Pulmonary removal and production of endothelin in the anesthetized dog. J Appl Physiol 1994;76:694-700.
17. Dupuis J, Cernacek P, Tardif JC, Stewart DJ, Gosselin G, Dyrda I, et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J 1998;135:614-20.
18. Ozaki S, Ohwaki K, Ihara M, Fukuroda T, Ishikawa K, Yano M. ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem Biophys Res Commun 1995;209:483-9.
19. Driss AB, Devaux C, Henrion D, Duriez M, Thuillez C, Levy BI, et al. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000;101:2764-70.
20. Huang H, Arnal JF, Llorens-Cortes C, Challah M, Alhenc-Gelas F, Covol P, et al. Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction. Circ Res 1994;75:454-61.
21. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1991;114:464-9.
22. Gratton JP, Cournoyer G, Loffler BM, Sirois P, D'Orleans-Juste P. ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension 1997;30:1204-9.
23. Wada A, Tsutamoto T, Fukai D, Ohnishi M, Maeda K, Hisanaga T, et al. Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure. J Am Coll Cardiol 1997;30:1385-92.
24. Givertz MM, Colucci WS, LeJemtel TH, Gottlieb SS, Hare JM, Slawsky MT, et al. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation 2000;101:2922-7.
25. McCulloch KM, Docherty CC, Morecroft I, MacLean MR. EndothelinB receptor-mediated contraction in human pulmonary resistance arteries. Br J Pharmacol 1996;119:1125-30.
26. MacLean MR, McCulloch KM, Baird M. Endothelin ETA- and ETB-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol 1994;23:838-45.
27. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JC Jr. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992;67:719-24.
28. Magga J, Vuolteenaho O, Marttila M, Ruskoaho H. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ETA/ETB and AT1 receptor antagonists in vivo and in vitro. Circulation 1997;96:3053-62.